This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (eHealth) (538) Coronary Heart Disease (81)

Published on in Vol 9, No 9 (2020): September

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/19456, first published .
Telomerase Activation to Reverse Immunosenescence in Elderly Patients With Acute Coronary Syndrome: Protocol for a Randomized Pilot Trial

Telomerase Activation to Reverse Immunosenescence in Elderly Patients With Acute Coronary Syndrome: Protocol for a Randomized Pilot Trial

Telomerase Activation to Reverse Immunosenescence in Elderly Patients With Acute Coronary Syndrome: Protocol for a Randomized Pilot Trial

Authors of this article:

Rebecca Maier1 Author Orcid Image ;   Bilal Bawamia2 Author Orcid Image ;   Karim Bennaceur3 Author Orcid Image ;   Sarah Dunn1 Author Orcid Image ;   Leanne Marsay1 Author Orcid Image ;   Roland Amoah3 Author Orcid Image ;   Adetayo Kasim4 Author Orcid Image ;   Andrew Filby5 Author Orcid Image ;   David Austin2 Author Orcid Image ;   Helen Hancock1 Author Orcid Image ;   Ioakim Spyridopoulos3 Author Orcid Image
Article Authors Cited by (16) Tweetations (1) Metrics

Rebecca Maier   1 , MSc ;   Bilal Bawamia   2 , MBBS, MRCP ;   Karim Bennaceur   3 , PhD ;   Sarah Dunn   1 , MSc ;   Leanne Marsay   1 , PhD ;   Roland Amoah   3 , MBBS ;   Adetayo Kasim   4 , PhD ;   Andrew Filby   5 , PhD ;   David Austin   2 , MD, FRCP ;   Helen Hancock   1 , PhD ;   Ioakim Spyridopoulos   3 , MD, FRCP

1 Newcastle Clinical Trials Unit, Newcastle University, Newcastle Upon Tyne, United Kingdom

2 James Cook University Hospital, Middlesbrough, United Kingdom

3 Institute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom

4 Wolfson Research Institute for Health and Wellbeing, Durham University, Durham, United Kingdom

5 Flow Cytometry Core Facility, Newcastle University, Newcastle Upon Tyne, United Kingdom

Corresponding Author: